Loading patent…
AssigneeSanten Pharmaceutical Co., Ltd.
InventorsKenji MORISHIMA, Hiroyuki ASADA, Yusuke MOMOKAWA, Asuka KAMIMURA, Kenichi ENDO
Estimating the term…
Provided is an ophthalmic composition comprising diquafosol or a salt thereof, a vinyl-based polymer and a cellulose-based polymer. Also provided is an agent for prevention or treatment of dry eyes, comprising diquafosol or a salt thereof, a vinyl-based polymer and a cellulose-based polymer. These solution-type aqueous eye drop for treatment of dry eye each comprises diquafosol sodium with a concentration of 3% (w/v), hydroxyethyl cellulose and polyvinylpyrrolidone having a K value of 30, and is characterized in that a single dose of 1 to 2 drops is administered by eye drop three times per day.
An ophthalmic composition comprising diquafosol or a salt thereof, a vinyl-based polymer and a cellulose-based polymer.
A preventive or therapeutic agent for dry eye comprising diquafosol or a salt thereof, a vinyl-based polymer and a cellulose-based polymer.
A solution-type aqueous eye drop for treatment of dry eye comprising diquafosol sodium with a concentration of 3% (w/v), hydroxyethyl cellulose and polyvinylpyrrolidone having a K value of 30, wherein the eye drop is characterized by being instilled into an eye 3 times a day in a dose of 1 or 2 drops each time.
Dependencies are inferred from the claim text.